CVS Health Corp. diskutieren
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
61,97 €
-0,32 %
CVS Health (NYSE:CVS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Wolfe Research from $85.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Robert W. Baird from $82.00 to $92.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Mizuho from $88.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Truist Financial Corporation from $95.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $93.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at TD Cowen from $100.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at JPMorgan Chase & Co. from $93.00 to $101.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target lowered by analysts at Bank of America Corporation from $100.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target lowered by analysts at Argus from $91.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Danaher Corp. diskutieren